Sulfoalkyl ether-alkyl ether cyclodextrin derivatives, their synthesis, NMR characterization, and binding of 6α-methylprednisolone

Journal of Pharmaceutical Sciences

Volumn 94, Issue 11, 2005, Pages 2380-2392

  Tongiani, Serena ^a,b   Vander Velde, David ^a   Ozeki, Tetsuya ^a,c   Stella, Valentino J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF URBINO   (Italy)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

6 Methylprednisolone; Binding constants; Cyclodextrin; Inclusion compounds; Modified cyclodextrins; NMR spectroscopy; Synthesis; UV Vis spectroscopy

Indexed keywords

ALKYL ETHER; ALKYLATING AGENT; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; METHYLPREDNISOLONE; ORGANIC SOLVENT; SULFATE; SULFUR DERIVATIVE; SULTONE;

ALKYLATION; AQUEOUS SOLUTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; DRUG BINDING; DRUG SYNTHESIS; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION; SOLUBILITY; TECHNIQUE; ULTRAFILTRATION;

EID: 30544442698     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20367     Document Type: Article

References (27)

1. Szejtli J. 1982. Cyclodextrins and their inclusion complexes, Akadémiai Kiadó, Budapest.
2. Frank DW, Gray JE, Weaver RN. 1976. Cyclodextrin Nephrosis in the Rat. Am J Pathol 83:367-374.
3. Irie T, Otagiri M, Sunanda M, Uekama K, Ohtani Y, Sugiyama Y. 1982. Cyclodextrins-induced hemolysis and shape changes of human erytrocytes in vitro. J Pharmacobiodyn 5:741-744.
4. Uekama K. 2004. Pharmaceutical applications of cyclodextrins as multi-functional drug carriers. Yakugaku Zasshi 124:909-935.
5. Szejtli J. 1988. Cyclodextrin technology. Dordrecht, The Netherlands: Kluwer Academic Publishers.
6. Frömming KH, Szejtli J. 1994. Cyclodextrins in pharmaceutical technology. Boston: Kluwer, Dordrect.
7. Loftsson T, Brewster M. 1996. Pharmaceutical applications of cyclodextrins. J Pharm Sci 85:1017-1025.
8. Easton KJ, Lincoln SF. 1999. Modified cyclodextrins, Scaffold and templates for supramolecular chemistry. Imperial College Press.
9. Tian S, Zhu H, Forgo P, D'Souza VT. 2000. Selectively monomodified cyclodextrins, synthetic strategies. J Org Chem 65(9):2624-2630.
10. Thompson DO, Siebert JM, Krol T, Hecker D. 2004. Cyclodextrins-enabling excipients: Their present and future use in pharmaceutics. 228th ACS National Meeting Philadelphia, PA.
11. Brewster ME, Loftsson T. 2002. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie 57(2):94-101.
12. Yoshida A, Arima H, Uekama K, Pitha J. 1988. Pharmaceutical evaluation of hydroxyalkyl ethers of b cyclodextrin. Int J Pharm 46(3):211-222.
13. Hiasa Y, Ohshima M, Kitahori Y, Konishi N, Fujita T, Yuasa T. 1982. Beta-cyclodextrin: Promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine. J Natl Cancer Inst 69(4):963-967.
14. Blanchard J, Proniuk S. 1999. Some important consideration in the use of cyclodextrins. Pharm Res 16(12):1796-1798.
15. Lemesle-Lamache V, Wouessidjewe D, Taverna M, Ferrier D, Perly B, Duchene D. 1997. Physicochemical characterization of different batches of ethylated beta-cyclodextrins. J Pharm Sci 86(9):1051-1056.
16. Rajewski RA, Traiger G, Bresnahan J, Jaberaboansar P, Stella VJ, Thompson DO. 1995. Preliminary safety evaluation of parenterally administered sulfoalkyl ether β-cyclodextrin derivatives. J Pharm Sci 84(8):927-932.
17. Ortholand JY, Ganesen A. 2004. Natural products and combinatorial chemistry: Back to the future. Curr Opin Chem Biol 8(3):271-280.
18. Rong D, D'Souza VT. 1990. A convinient method for functionalization of the second position of cyclodextrins. Tetrahedron Lett 31:4275-4278.
19. Brewster M, Huang MJ, Pop E, Pitha J, Dewar MJS, Kaminski JJ, Bodor N. 1993. An AM1 molecular orbital study of a-D-glucose and B-maltose: Evaluation and implications. Carbohydr Res 242:53-67.
20. Jindrich J, Pitha J, Lindberg B, Seffers P, Harata K. 1995. Regioselectivity of alkylation of cyclomaltohepraose (β-Cyclodextrin) and synthesis of its mono-2-O-methyl, -ethyl, -allyl, and -propyl derivatives. Carbohyd Res 266(1):75-80.
21. Stella VJ, Rajewski RA. 1996. Derivatives of cyclodextrins exhibiting enhanced aqueous solubility, and the use thereof. JUS Patent 5:376-645.
22. Bax A, Griffey RH, Hawkins BL. 1983. Correlation of proton and nitrogen-15 chemical shifts by multiple quantum NMR. J Magn Reson 55:301-315.
23. In an abstract in the program for the 12th International Cyclodextrin Symposium held in Montpellier, France, on May 46-49, 2004 an error stating the SAE substitution was 2 > 6> 3 should have read 2 > 3 > 6. The poster and the proceedings from that meeting correctly state that SAE substitution was 2 > 3 > 6, consistent with the finding of this paper.
24. Larsen KL, Aachmann FL, Wimmer R, Stella VJ, Kjølner UM. 2005. Phase solubility and structure of the inclusion complexes of prednisolone and 6a-methylprednisolone with various cyclodextrins. J Pharm Sci 94:507-515.
25. Sadlej-Sosnowska N. 1997. Influence of the structure of steroid hormones on their association with cyclodextrins: A high-performance liquid chromatography study. J Indus Phen Mol Recog Chem 27:31-40.
26. Foster R, Hammich DL, Wardley AA. 1953. Interaction of polynitro compounds with aromatic hydroquinones and bases. Part III. A new method for determining the association constant for certain interactions between nitro-compounds and bases solution. J Chem Soc Abstracts 3812-3820.
27. Higuchi T, Connors KA. 1965. Advance in analytical chemistry and instrumentation. C.N. Reilly. Interscience, New York.